Svai Sanford
2022
In 2022, Svai Sanford earned a total compensation of $2M as Chief Financial Officer at Rani Therapeutics Holdings, a 58% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $249,600 |
---|---|
Option Awards | $888,460 |
Salary | $412,000 |
Stock Awards | $434,609 |
Total | $1,984,669 |
Sanford received $888.5K in option awards, accounting for 45% of the total pay in 2022.
Sanford also received $249.6K in non-equity incentive plan, $412K in salary and $434.6K in stock awards.
Rankings
In 2022, Svai Sanford's compensation ranked 1,760th out of 5,753 executives tracked by ExecPay. In other words, Sanford earned more than 69.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,760 | 69th |
Manufacturing | 925 | 71st |
Chemicals And Allied Products | 374 | 74th |
Drugs | 342 | 74th |
Pharmaceutical Preparations | 246 | 75th |
Sanford's colleagues
We found two more compensation records of executives who worked with Svai Sanford at Rani Therapeutics Holdings in 2022.